ExpiresJuly 12, 2019
National Jewish Health
The Severe Asthma Roadmap to Improved Diagnosis and Treatment. A Guided Workflow is a case-based simulation online enduring and live program that includes six live evening symposia. This program will present two patient simulation cases designed to challenge treating HCPs in a learning experience that reflects the real world and how asthma can present in their practice. Each case is designed to specifically and continually challenge learners about diagnosis, treatment, teaming and participatory strategies. Cases will focus on making clinical decisions related to the workup and diagnosis of severe asthma, adherence, assessment, and personalized treatment selection.
Elements from the online case-based simulations will be integrated into the live activities, such as animation of the underlying technique as it relates to adherence. Additionally, development and provision of an infographic workflow to guide physicians in the appropriate workup to differentiate severe asthma from difficult-to-treat asthma and will serve as a clinical reference aid for physicians to reinforce learning and encourage uptake.
A substantial proportion of the suboptimal outcomes in asthma are related to adherence and evidence shows that with proper evaluation, severe asthma, patients are poised to benefit from new and emerging personalized therapy. New biologic medications recently approved and currently in development will offer new options, but increase complexity in that they are effective only for patients with certain asthma subtypes.
ABMS Member Board Approvals by Type
ABMS MOC Part II CME Activity
Allergy and Immunology
NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
1. Describe key concepts in the pathophysiology of severe asthma and the features that are targets for biologic therapies.
2. Distinguish severe asthma from difficult-to-treat asthma with improved diagnosis and assessment strategies, including proper inhaler technique.
3. Review emerging evidence related to targeted therapies and potential biomarkers to select personalized treatment in severe asthma according to asthma subtype.
Medical Knowledge, Patient Care & Procedural Skills
CME Credit Type
AMA PRA Category 1 Credit
Academic Medicine, Inpatient, Outpatient, Rural, Urban, VA/Military